CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09)

Authors :: Rothschild, S
Amrein, Michael
Riether, Carsten
Gautschi, O
Schuster, N
Li, Q
Savic, S
Schneider, M
Biaggi, C
Bubendorf, L
Brutsche, M
Zippelius, A
Zander, T
Betticher, D
Früh, M
Stahel, R
Cathomas, R
Rauch, Daniel
Pless, M
Ochsenbein, Adrian
Jaggi, R
Publication Year :: 2017
Publisher :: Elsevier, 2017.

Full Text Access

Tools